The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

Dr. Dyan Hes joined Fox 5 to share more on the connection between weight loss drugs and liver disease. Louis Serbeck, 54, ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

Nearly two in three people with fatty liver disease lost some of the liver fat and inflammation after using semaglutide 2.4 ...

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...

A study from the New England Journal of Medicine found new evidence that GLP-1 drugs used for diabetes and obesity could also ...

In a new study, Ozempic - a drug sold to help with obesity and diabetes - is attributed to helping this disease.

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.

Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...